0001425738-11-000010.txt : 20111114
0001425738-11-000010.hdr.sgml : 20111111
20111114163634
ACCESSION NUMBER: 0001425738-11-000010
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110930
FILED AS OF DATE: 20111114
DATE AS OF CHANGE: 20111114
EFFECTIVENESS DATE: 20111114
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Redmile Group, LLC
CENTRAL INDEX KEY: 0001425738
IRS NUMBER: 208592298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-12776
FILM NUMBER: 111203330
BUSINESS ADDRESS:
STREET 1: 100 PINE STREET, SUITE 1925
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-489-9980
MAIL ADDRESS:
STREET 1: 100 PINE STREET, SUITE 1925
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
13F-HR
1
red3q11.txt
3Q2011 13FHR
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
Form 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: September 30, 2011
Check here if Amendment [ ]; Amendment Number:
This Amendment (Check only one.): [ ] is a restatement.
[ ] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Redmile Group, LLC
Address: 100 Pine Street
Suite #1925
San Francisco, CA 94111
13F File Number: 028-12776
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Jeremy Green
Title: Managing Member
Phone: 415-489-9980
Signature, Place, and Date of Signing:
/s/ Jeremy Green San Francisco, CA November 15, 2011
Report Type (Check only one.):
[ X] 13F HOLDINGS REPORT.
[ ] 13F NOTICE.
[ ] 13F COMBINATION REPORT.
FORM 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 0
Form 13F Information Table Entry Total: 30
Form 13F Information Table Value Total: $205,650 (thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional managers with respect to which this report is filed, other
than the manager filing this report.
NONE
FORM 13F INFORMATION TABLE
VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE
------------------------------ ---------------- --------- -------- -------- --- ---- ------- ------------ -------- -------- --------
ALIGN TECHNOLOGY INC COM 016255101 11608 765200 SH Defined 76520 0
AMICUS THERAPEUTICS INC COM 03152W109 122 31900 SH Defined 3190 0
ANTHERA PHARMACEUTICALS INC COM 03674U102 3563 747060 SH Defined 74706 0
ARIAD PHARMACEUTICALS INC COM 04033A100 15316 1742450 SH Defined 174245 0
ARTHROCARE CORP COM 043136100 6617 230000 SH Defined 23000 0
AUXILIUM PHARMACEUTICALS INC COM 05334D107 8404 560614 SH Defined 56061 4
AVI BIOPHARMA INC COM 002346104 580 517792 SH Defined 51779 2
BAXTER INTL INC COM 071813109 7848 139800 SH Defined 13980 0
BIOSPECIFICS TECHNOLOGIES CO COM 090931106 6487 401875 SH Defined 40187 5
CAREFUSION CORP COM 14170T101 13891 580000 SH Defined 58000 0
CONMED CORP COM 207410101 6533 283934 SH Defined 28393 4
CUTERA INC COM 232109108 5315 746500 SH Defined 74650 0
CYCLACEL PHARMACEUTICALS INC COM 23254L108 780 1772879 SH Defined 177287 9
DYNAVAX TECHNOLOGIES CORP COM 268158102 9942 5345010 SH Defined 534501 0
EXPRESS SCRIPTS INC COM 302182100 10643 287100 SH Defined 28710 0
GILEAD SCIENCES INC COM 375558103 13892 358029 SH Defined 35802 9
GTX INC DEL COM 40052B108 4114 1228200 SH Defined 122820 0
INCYTE CORP COM 45337C102 6352 454722 SH Defined 45472 2
LEMAITRE VASCULAR INC COM 525558201 1792 286331 SH Defined 28633 1
MEDIVATION INC COM 58501N101 3759 221400 SH Defined 22140 0
MEDTRONIC INC COM 585055106 6648 200000 SH Defined 20000 0
NEKTAR THERAPEUTICS COM 640268108 5707 1176686 SH Defined 117668 6
NPS PHARMACEUTICALS INC COM 62936P103 4927 756900 SH Defined 75690 0
ONYX PHARMACEUTICALS INC COM 683399109 18595 619641 SH Defined 61964 1
SAVIENT PHARMACEUTICALS INC COM 80517Q100 71 17400 SH Defined 1740 0
SEQUENOM INC COM NEW 817337405 12621 2479503 SH Defined 247950 3
SYNTA PHARMACEUTICALS CORP COM 87162T206 893 274841 SH Defined 27484 1
TRANS1 INC COM 89385X105 1800 600093 SH Defined 60009 3
TRIUS THERAPEUTICS INC COM 89685K100 5163 819400 SH Defined 81940 0
UNITED THERAPEUTICS CORP DEL COM 91307C102 11667 311200 SH Defined 31120 0